Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cell Therapy Transplant Canada (CTTC), formerly known as the Canadian Blood and Marrow Transplant Group, is a member-led, national multidisciplinary organization dedicated to the field of hematopoietic stem cell transplantation and cell therapy. The organization promotes excellence in patient care, research, and education through the development of evidence-based clinical practice guidelines and the facilitation of national clinical trials. CTTC serves as the primary professional body for physicians, nurses, and laboratory scientists in Canada, providing a platform for networking and professional development. It also maintains a national registry to monitor transplant outcomes and advocates for high standards in cellular therapy across the Canadian healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian Blood and Marrow Transplant Group.